United States

Core AFFO (TTM)

Core AFFO/share (TTM)

Core AFFO/share Guidance

Core AFFO (Quarter)

Core AFFO/share (Quarter)

Price per share at the end of the period divided by the last reported earnings

Price/Core AFFO

Same Property Occupancy

MAA is an S&P 500 company and real estate investment trust (REIT), focused on delivering full-cycle and strong investment performance for shareholders through the ownership, management, acquisition, development and redevelopment of quality apartment communities. With an investment portfolio that is uniquely balanced and diversified across the high growth Southeast, Southwest and Mid-Atlantic regions of the U.S., MAA has successfully navigated numerous business cycles, captured significant growth and built an efficient, technology-driven operating platform.

Mid-America

The main earnings metric reported by the REIT

If the REIT is managed by an internal (employees) or external (separate company) team

As a long-term debt issuer, MAA is classified as investment grade

Period: 2022 Q2

Years since IPO: 15/15,
Core AFFO Growth: 10/15,
Core AFFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2022 Q3

Years since IPO: 15/15,
Core AFFO Growth: 10/15,
Core AFFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2022 Q4

Years since IPO: 15/15,
Core AFFO Growth: 13/15,
Core AFFO/share Growth: 18/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2023 Q1

Years since IPO: 15/15,
Core AFFO Growth: 10/15,
Core AFFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2023 Q2

Years since IPO: 15/15,
Core AFFO Growth: 10/15,
Core AFFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2023 Q3

Years since IPO: 15/15,
Core AFFO Growth: 15/15,
Core AFFO/share Growth: 20/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2023 Q4

Years since IPO: 15/15,
Core AFFO Growth: 13/15,
Core AFFO/share Growth: 18/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2024 Q1

Years since IPO: 15/15,
Core AFFO Growth: 15/15,
Core AFFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2024 Q2

Years since IPO: 15/15,
Core AFFO Growth: 15/15,
Core AFFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2024 Q3

Years since IPO: 15/15,
Core AFFO Growth: 15/15,
Core AFFO/share Growth: 20/20,
Dividend Growth: 15/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2024 Q4

Years since IPO: 15/15,
Core AFFO Growth: 10/15,
Core AFFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Period: 2025 Q1

Years since IPO: 15/15,
Core AFFO Growth: 10/15,
Core AFFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 15/15
            

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's Core AFFO

Core AFFO Growth

Assessment of recent increases in Core AFFO per share, indicating profitability

Core AFFO/share Growth

Analysis of the recent Dividend track record

Dividend Growth

Payout level to determine if the dividend is safe

Payout Ratio

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

@brownreport's Jason Brown says he's cautious for the market's short-term trading action but bullish on long-term prospects. On his Big 3, he talks about Alphabet's (GOOGL) new A.I.

The Big 3: GOOGL, MAA, MGM

GERMANTOWN, Tenn. , May 20, 2025 /PRNewswire/ -- Mid-America Apartment Communities, Inc., or MAA (NYSE: MAA), today announced that its board of directors approved a quarterly dividend payment of $1.5150 per share of common stock to be paid on July 31, 2025, to shareholders of record on July 15, 2025.

MAA Announces Quarterly Common Dividend

REITs, or real estate investment trusts, own, operate, or finance income-producing real estate.

Goldman Sachs Says Bet on Sun Belt REITs: 3 Top Picks Pay Large, Dependable Dividends

GERMANTOWN, Tenn. , April 30, 2025 /PRNewswire/ -- Mid-America Apartment Communities, Inc., or MAA (NYSE: MAA), today announced operating results for the three months ended March 31, 2025.

MAA REPORTS FIRST QUARTER 2025 RESULTS

Stock market sell-offs like the one we're currently experiencing are challenging periods for investors. However, with every challenge comes an opportunity to improve.

Stock Market Sell-Off Shopping Spree: 3 Top Dividend Stocks I Just Bought to Boost My Passive Income

GERMANTOWN, Tenn. , April 2, 2025 /PRNewswire/ -- MAA (NYSE: MAA) announced today that the Company expects to release its first quarter 2025 results on Wednesday, April 30, 2025, after market close and will hold a conference call on Thursday, May 1, 2025, at 9:00 a.m.

MAA Announces Date of First Quarter Earnings Release, Conference Call

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for paltusotine, the first once-daily, oral, selectively-targeted somatostatin receptor type 2 nonpeptide agonist, for the proposed treatment and long-term maintenance therapy of acromegaly, a serious, rare and progressive endocrine disorder characterized by consistently elevated levels of growth hormone. The MAA will now be reviewed by the Committee for Medicinal Products for Human Use (CHMP).   Additionally, the EMA on February 27, 2025 granted paltusotine Orphan Drug Designation (ODD) for the treatment of acromegaly.

Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for apitegromab, an investigational muscle-targeted treatment that is being developed to provide clinically meaningful improvement in motor function for.

FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy

GERMANTOWN, TENN. , MAY 20, 2025 /PRNEWSWIRE/ -- MID-AMERICA APARTMENT COMMUNITIES, INC., OR MAA (NYSE: MAA),TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS APPROVED A QUARTERLY DIVIDEND PAYMENT OF $1.5150 PER SHARE OF COMMON STOCK TO BE PAID ON JULY 31, 2025, TO SHAREHOLDERS OF RECORD ON JULY 15, 2025.

MAA ANNOUNCES QUARTERLY COMMON DIVIDEND

GERMANTOWN, TENN. , APRIL 30, 2025 /PRNEWSWIRE/ --MID-AMERICA APARTMENT COMMUNITIES, INC., OR MAA (NYSE: MAA), TODAY ANNOUNCED OPERATING RESULTS FOR THE THREE MONTHS ENDED MARCH31, 2025.

GERMANTOWN, TENN. , APRIL 2, 2025 /PRNEWSWIRE/ -- MAA (NYSE: MAA)ANNOUNCED TODAY THAT THE COMPANY EXPECTS TO RELEASE ITS FIRST QUARTER 2025 RESULTS ON WEDNESDAY, APRIL 30, 2025, AFTER MARKET CLOSE AND WILL HOLD A CONFERENCE CALL ON THURSDAY, MAY 1, 2025, AT 9:00 A.M.

MAA ANNOUNCES DATE OF FIRST QUARTER EARNINGS RELEASE, CONFERENCE CALL

SAN DIEGO, MARCH 27, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY ANNOUNCED THAT THE EUROPEAN MEDICINES AGENCY (EMA) HAS VALIDATED THE MARKETING AUTHORIZATION APPLICATION (MAA) FOR PALTUSOTINE, THE FIRST ONCE-DAILY, ORAL, SELECTIVELY-TARGETED SOMATOSTATIN RECEPTOR TYPE 2 NONPEPTIDE AGONIST, FOR THE PROPOSED TREATMENT AND LONG-TERM MAINTENANCE THERAPY OF ACROMEGALY, A SERIOUS, RARE AND PROGRESSIVE ENDOCRINE DISORDER CHARACTERIZED BY CONSISTENTLY ELEVATED LEVELS OF GROWTH HORMONE. THE MAA WILL NOW BE REVIEWED BY THE COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP). ADDITIONALLY, THE EMA ON FEBRUARY 27, 2025 GRANTED PALTUSOTINE ORPHAN DRUG DESIGNATION (ODD) FOR THE TREATMENT OF ACROMEGALY.

CRINETICS PHARMACEUTICALS ANNOUNCES EUROPEAN MEDICINES AGENCY (EMA) VALIDATION OF MARKETING AUTHORIZATION APPLICATION (MAA) AND ORPHAN DRUG DESIGNATION (ODD) FOR PALTUSOTINE IN ACROMEGALY

CAMBRIDGE, MASS.--(BUSINESS WIRE)--SCHOLAR ROCK (NASDAQ: SRRK), A LATE-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON ADVANCING INNOVATIVE TREATMENTS FOR NEUROMUSCULAR DISEASES, CARDIOMETABOLIC DISORDERS, AND OTHER SERIOUS DISEASES, TODAY ANNOUNCED THAT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED ITS BIOLOGICS LICENSE APPLICATION (BLA) FOR APITEGROMAB, AN INVESTIGATIONAL MUSCLE-TARGETED TREATMENT THAT IS BEING DEVELOPED TO PROVIDE CLINICALLY MEANINGFUL IMPROVEMENT IN MOTOR FUNCTION FOR.

FDA GRANTS PRIORITY REVIEW FOR BIOLOGICS LICENSE APPLICATION (BLA) AND EMA ACCEPTS MARKETING AUTHORISATION APPLICATION (MAA) FOR APITEGROMAB AS A TREATMENT FOR SPINAL MUSCULAR ATROPHY

GERMANTOWN, TENN. , MARCH 18, 2025 /PRNEWSWIRE/ -- MID-AMERICA APARTMENT COMMUNITIES, INC., OR MAA (NYSE: MAA),TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS APPROVED A QUARTERLY DIVIDEND PAYMENT OF $1.5150 PER SHARE OF COMMON STOCK TO BE PAID ON APRIL 30, 2025, TO SHAREHOLDERS OF RECORD ON APRIL 15, 2025.

GERMANTOWN, TENN. , MARCH 3, 2025 /PRNEWSWIRE/ --MID-AMERICA APARTMENT COMMUNITIES, INC., OR MAA (NYSE: MAA),TODAY ANNOUNCED A FULL QUARTERLY DIVIDEND OF $1.0625 PER OUTSTANDING SHARE OF ITS 8.50% SERIES I CUMULATIVE REDEEMABLE PREFERRED STOCK.

MAA ANNOUNCES REGULAR QUARTERLY PREFERRED DIVIDEND

GERMANTOWN, TENN. , FEB.28, 2025 /PRNEWSWIRE/ -- MID-AMERICA APARTMENT COMMUNITIES, INC., OR MAA (NYSE: MAA), TODAY ANNOUNCED THAT THE COMPANY PLANS TO PARTICIPATE IN THE 2025 CITI GLOBAL PROPERTY CEO CONFERENCE.

MAA TO PARTICIPATE IN THE 2025 CITI GLOBAL PROPERTY CEO CONFERENCE

GERMANTOWN, TENN. , FEB. 5, 2025 /PRNEWSWIRE/ -- MID-AMERICA APARTMENT COMMUNITIES, INC., OR MAA (NYSE: MAA), TODAY ANNOUNCED OPERATING RESULTS FOR THE THREE MONTHS ENDED DECEMBER 31, 2024.

MAA REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

GERMANTOWN, TENN. , JAN. 21, 2025 /PRNEWSWIRE/ -- MID-AMERICA APARTMENT COMMUNITIES, INC. OR MAA (NYSE: MAA) TODAY ANNOUNCED THE TAXABLE COMPOSITION OF THE 2024 DISTRIBUTIONS PAID TO SHAREHOLDERS.

MAA ANNOUNCES TAXABLE COMPOSITION OF 2024 DISTRIBUTIONS

GERMANTOWN, TENN. , JAN. 16, 2025 /PRNEWSWIRE/ --MAA (NYSE: MAA) ANNOUNCED TODAY THAT THE COMPANY EXPECTS TO RELEASE ITS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS ON WEDNESDAY, FEBRUARY 5, 2025, AFTER MARKET CLOSE AND WILL HOLD A CONFERENCE CALL ON THURSDAY, FEBRUARY 6, 2025, AT 9:00 A.M.

Mid-America

MAA

Price

Dividends

Yield

Dividends

No items found.

Financials Overview

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Press Releases

Related News, Articles and Videos

Historical Scores

You might also be interested in

MAA.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Dividends

Yield

Dividends

No items found.

Financials Overview

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Press Releases

Related News, Articles and Videos

Historical Scores

You might also be interested in

MAA